skip to main content

Paul, Weiss is widely recognized as having one of the nation’s preeminent securities litigation and regulatory practices. For two decades, our lawyers have guided global corporations and financial institutions through a series of “bet-the-company” securities-related crises, consistently reducing or eliminating their most damaging claims and negotiating favorable resolutions.

Publications

Client News

Morgan Stanley Wins Dismissal of Class Action Concerning U.S. Treasury Securities Trading

Paul, Weiss achieved a major victory for Morgan Stanley when District Judge Paul G. Gardephe of the Southern District of New York dismissed a class action against several financial institutions that participate in the auction and trading of securities issued by the U.S. Treasury.

» more

Awards & Recognition

Client News

Underwriters of Venator’s IPO Win Dismissal of Securities Claims

Paul, Weiss secured the dismissal of Securities Act claims against our clients, underwriters of an IPO by UK-based pigment maker Venator Materials PLC, when the New York Supreme Court dismissed a putative class action as time-barred.

» more

Client News

Teladoc Secures Magistrate’s Recommendation of Dismissal of Derivative Action

In a decision likely spelling the end of the case, a magistrate judge recommended that a shareholder derivative action against 17 current or former directors and officers of Teladoc Health, Inc. be dismissed with prejudice. Paul, Weiss is defending the Teladoc defendants in the case.

» more

Publications

Update: Mitigating Securities Litigation Risks Related to the Coronavirus

As an update to our earlier alert, “Mitigating Securities Litigation Risks Related to the Coronavirus,” we look at key takeaways from the first two securities fraud class action filings related to COVID-19 disclosures and outline additional steps companies can take to mitigate the risks associated with COVID-19-linked shareholder litigation.  

» more

Publications

SEC Charges Company with COVID-19-Related Securities Fraud, Reaffirming its Focus on Public Statements and Disclosures Relating to COVID-19

The SEC recently brought its first enforcement action arising out of the COVID-19 pandemic. The action reaffirms the Commission’s laser focus on companies’ statements concerning, and responses to, the pandemic. 

» more

Publications

Federal District Court Determines That Pharmaceutical Company Has No Standalone Obligation to Disclose Interim FDA Feedback on Form 483

A federal district court dismissed a putative securities class action lawsuit against Nabriva Therapeutics and several of its officers alleging that the company had fraudulently misled investors about its prospects for getting FDA approval for its new drug, CONTEPO.

» more

Client News

Paul, Weiss Wins Dismissal of Securities Class Action Against Ericsson

Paul, Weiss secured the dismissal of a putative securities class action brought against our clients Telefonaktiebolaget LM Ericsson and various Ericsson executives relating to Ericsson’s accounting for various long-term service contracts.

» more

Client News

Paul, Weiss Wins Dismissal of Securities Claims Against CBS Lead Independent Director Arising From Former CEO’s Alleged Sexual Misconduct

Paul, Weiss secured a major victory for Bruce Gordon, the former lead independent director of the board of CBS Corporation, in a putative securities class action arising from former CEO and Chairman Leslie Moonves’ and others’ sexual misconduct.

» more

Publications

Mitigating Securities Litigation Risks Related to the Coronavirus

The spread of coronavirus has disrupted global businesses and triggered severe U.S. stock market declines. These events raise the risk that shareholders will convert these stock drops into litigation. We address the securities litigation risks and suggest steps companies may decide to take to mitigate these risks.

» more

Client News

Paul, Weiss Wins Dismissal of Securities Class Action Against Oaktree

Paul, Weiss secured the dismissal, with prejudice, of a putative securities class action brought against our client Oaktree Capital Management, L.P. relating to Oaktree’s investment in Tribune Media Company.

» more

Client News

Paul, Weiss Defeats Attempt to Revive Securities Class Action Against Pretium

Paul, Weiss achieved another victory for Pretium Resources Inc. and two executives when the U.S. District Court for the Southern District of New York denied plaintiffs’ motion for leave to amend their complaint following dismissal of a securities class action alleging that Pretium had defrauded investors.

» more

Videos

The Impact of CalPERS v. ANZ Securities on Securities Litigation

In CalPERS v. ANZ Securities, the Supreme Court ruled that the filing of a class action does not toll the Securities Act’s three-year statute of repose. 

» more

Client News

Meridian Bioscience Wins Dismissal of Securities Class Action

Paul, Weiss secured the dismissal of a putative securities class action against our client Meridian Bioscience, an Ohio-based life science company.

» more

© 2021 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy